Vaccine Design and Testing – News and Features

Dalton will use a proprietary Thermo Fisher manufacturing process to produce nucleic-acid biopolymers for pharmaceutical use.

Genostar's IOGMA® 3.4 is a new package that integrates three modules of company's bioinformatics products, to aid understanding of pathogens causing animal diseases.

Genostar has announced that Merial has purchased its IOGMA(R) 3.4 Metabolic Pathway Builder software.

ITI Life Sciences’ is seeking to commission a new R&D programme to develop technologies that can be further developed to create high-value commercial products.

The study suggests a role for Homspera in boosting the human immune system.

The findings may help explain why species can almost never interbreed, and also point to a possible way to thwart the spread of malaria.

Researchers have shown that vaccinating mice with a modified form of a virus containing proteins from breast cancer cells can kill large breast cancer tumors and tumors that have spread to the lungs.

The collaborative research and exclusive license agreement will develop new technologies for vaccine research and production.

An improved understanding of how the immune system operates during a viral infection is critical to designing successful anti-virus vaccines, scientists say.

Scientific paper “DNA vaccines: precision tools for activating effective immunity against cancer” now available in the February 2008 issue of Nature Reviews Cancer.